Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prodrug Supercarriers
- Development stage
- Preclinical
- Lead developer
- Temprian Oncology
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Parenteral
01
Overview
Prodrug Supercarriers are a nanoparticle-based delivery system developed by Temprian Oncology (a subsidiary of Temprian Therapeutics) for the treatment of metastatic melanoma. Developed in collaboration with Northwestern University's Le Poole and Nguyen Laboratories, these "Supercarriers" utilize MBEH (monobenzone) nanoparticle technology to encapsulate a cytotoxic payload. The delivery vehicle is engineered to be stable in systemic circulation but undergoes a conformational change to release its active cytotoxic ingredient specifically within the low-pH environment of melanosomes—specialized organelles in melanoma cells. This targeted approach aims to maximize therapeutic efficacy against tumor cells while minimizing off-target systemic toxicity.
- Other names
- SupercarriersMBEH nanoparticle technology
02
Targets
TYR (Tyrosinase)
Beyond the preview
Go deeper on Prodrug Supercarriers.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prodrug Supercarriers.